help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haffner, S. M.
Right arrow Articles by Stern, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haffner, S. M.
Right arrow Articles by Stern, M. P.

Journal of Clinical Endocrinology & Metabolism, Vol 77, 56-60, Copyright © 1993 by Endocrine Society


ARTICLES

Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men

SM Haffner, RA Valdez, PA Morales, HP Hazuda and MP Stern
Department of Medicine, University of Texas Health Science Center, San Antonio 78284-7873.

Sex hormones may influence risk factors for noninsulin-dependent diabetes mellitus (NIDDM). Decreased sex hormone-binding globulin (SHBG; an indirect measure of androgenicity) is associated with hyperinsulinemia and insulin resistance. We measured SHBG concentrations in 58 subjects who later converted to diabetes and 107 subjects who remained normoglycemic throughout the 8 yr of follow-up of the San Antonio Heart Study, a population-based study of diabetes and cardiovascular disease. Among premenopausal women, SHBG concentrations (nanomoles per L) were significantly lower in converters than in nonconverters (41.6 +/- 12.4 vs. 74.4 +/- 10.0; P = 0.004), but corresponding differences were not observed in postmenopausal women or in men. Since, however, analysis of variance suggested no significant interaction between menopausal status and conversion to NIDDM, we pooled pre- and postmenopausal women. Subsequent analysis indicated that SHBG concentrations predicted the development of NIDDM in women independently of glucose and insulin concentrations. We conclude that increased androgenicity, as assessed by decreased SHBG concentrations, is an important independent risk factor for NIDDM in women.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
B. Sternfeld, K. Liu, C. P. Quesenberry Jr., H. Wang, S.-F. Jiang, M. Daviglus, M. Fornage, C. E. Lewis, J. Mahan, P. J. Schreiner, et al.
Changes over 14 Years in Androgenicity and Body Mass Index in a Biracial Cohort of Reproductive-Age Women
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2158 - 2165.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. H. Wu, M. C. Yu, C.-C. Tseng, F. Z. Stanczyk, and M. C. Pike
Diabetes and risk of breast cancer in Asian-American women
Carcinogenesis, July 1, 2007; 28(7): 1561 - 1566.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. H. Golden, A. S. Dobs, D. Vaidya, M. Szklo, S. Gapstur, P. Kopp, K. Liu, and P. Ouyang
Endogenous Sex Hormones and Glucose Tolerance Status in Postmenopausal Women
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1289 - 1295.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
E. L. Ding, Y. Song, V. S. Malik, and S. Liu
Sex Differences of Endogenous Sex Hormones and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis
JAMA, March 15, 2006; 295(11): 1288 - 1299.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Sutton-Tyrrell, R. P. Wildman, K. A. Matthews, C. Chae, B. L. Lasley, S. Brockwell, R. C. Pasternak, D. Lloyd-Jones, M. F. Sowers, J. I. Torrens, et al.
Sex Hormone-Binding Globulin and the Free Androgen Index Are Related to Cardiovascular Risk Factors in Multiethnic Premenopausal and Perimenopausal Women Enrolled in the Study of Women Across the Nation (SWAN)
Circulation, March 15, 2005; 111(10): 1242 - 1249.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Kalme, M. Seppala, Q. Qiao, R. Koistinen, A. Nissinen, M. Harrela, M. Loukovaara, P. Leinonen, and J. Tuomilehto
Sex Hormone-Binding Globulin and Insulin-Like Growth Factor-Binding Protein-1 as Indicators of Metabolic Syndrome, Cardiovascular Risk, and Mortality in Elderly Men
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1550 - 1556.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. H. Golden, J. Ding, M. Szklo, M. I. Schmidt, B. B. Duncan, and A. Dobs
Glucose and Insulin Components of the Metabolic Syndrome Are Associated with Hyperandrogenism in Postmenopausal Women: The Atherosclerosis Risk in Communities Study
Am. J. Epidemiol., September 15, 2004; 160(6): 540 - 548.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Thadhani, J. L. Ecker, W. P. Mutter, M. Wolf, K. V. Smirnakis, V. P. Sukhatme, R. J. Levine, and S. A. Karumanchi
Insulin Resistance and Alterations in Angiogenesis: Additive Insults That May Lead to Preeclampsia
Hypertension, May 1, 2004; 43(5): 988 - 992.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
E. C. Tsai, A. M. Matsumoto, W. Y. Fujimoto, and E. J. Boyko
Association of Bioavailable, Free, and Total Testosterone With Insulin Resistance: Influence of sex hormone-binding globulin and body fat
Diabetes Care, April 1, 2004; 27(4): 861 - 868.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Cousin, L. Calemard-Michel, H. Lejeune, G. Raverot, N. Yessaad, A. Emptoz-Bonneton, Y. Morel, and M. Pugeat
Influence of SHBG Gene Pentanucleotide TAAAA Repeat and D327N Polymorphism on Serum Sex Hormone-Binding Globulin Concentration in Hirsute Women
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 917 - 924.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. M. Rexrode, J. E. Manson, I-M. Lee, P. M Ridker, P. M. Sluss, N. R. Cook, and J. E. Buring
Sex Hormone Levels and Risk of Cardiovascular Events in Postmenopausal Women
Circulation, October 7, 2003; 108(14): 1688 - 1693.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Sowers, C. Derby, M. L. Jannausch, J. I. Torrens, and R. Pasternak
Insulin Resistance, Hemostatic Factors, and Hormone Interactions in Pre- and Perimenopausal Women: SWAN
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4904 - 4910.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Jayagopal, E. S. Kilpatrick, P. E. Jennings, D. A. Hepburn, and S. L. Atkin
The Biological Variation of Testosterone and Sex Hormone-Binding Globulin (SHBG) in Polycystic Ovarian Syndrome: Implications for SHBG as a Surrogate Marker of Insulin Resistance
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1528 - 1533.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. M. Kalish, E. Barrett-Connor, G. A. Laughlin, and B. I. Gulanski
Association of Endogenous Sex Hormones and Insulin Resistance among Postmenopausal Women: Results from the Postmenopausal Estrogen/Progestin Intervention Trial
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1646 - 1652.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Cibula, J. Skrha, M. Hill, M. Fanta, L. Haakova, J. VrbIkova, and J. Zivny
Prediction of Insulin Sensitivity in Nonobese Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5821 - 5825.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Wolf, L. Sandler, R. Jimenez-Kimble, A. Shah, J. L. Ecker, and R. Thadhani
Insulin Resistance But Not Inflammation Is Associated With Gestational Hypertension
Hypertension, December 1, 2002; 40(6): 886 - 891.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Wolf, L. Sandler, K. Munoz, K. Hsu, J. L. Ecker, and R. Thadhani
First Trimester Insulin Resistance and Subsequent Preeclampsia: A Prospective Study
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1563 - 1568.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. E Roeters van Lennep, H.T. Westerveld, D.W. Erkelens, and E. E van der Wall
Risk factors for coronary heart disease: implications of gender
Cardiovasc Res, February 15, 2002; 53(3): 538 - 549.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Andersson, G. Johannsson, G. Holm, B.-A. Bengtsson, A. Sashegyi, I. Pavo, T. Mason, and P. W. Anderson
Raloxifene Does Not Affect Insulin Sensitivity or Glycemic Control in Postmenopausal Women with Type 2 Diabetes Mellitus: A Randomized Clinical Trial
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 122 - 128.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J.-Y. Oh, E. Barrett-Connor, N. M. Wedick, and D. L. Wingard
Endogenous Sex Hormones and the Development of Type 2 Diabetes in Older Men and Women: the Rancho Bernardo Study
Diabetes Care, January 1, 2002; 25(1): 55 - 60.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. G. Solomon, F. B. Hu, A. Dunaif, J. Rich-Edwards, W. C. Willett, D. J. Hunter, G. A. Colditz, F. E. Speizer, and J. E. Manson
Long or Highly Irregular Menstrual Cycles as a Marker for Risk of Type 2 Diabetes Mellitus
JAMA, November 21, 2001; 286(19): 2421 - 2426.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. Ibáñez, J. DiMartino-Nardi, N. Potau, and P. Saenger
Premature Adrenarche--Normal Variant or Forerunner of Adult Disease?
Endocr. Rev., December 1, 2000; 21(6): 671 - 696.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Couillard, J. Gagnon, J. Bergeron, A. S. Leon, D. C. Rao, J. S. Skinner, J. H. Wilmore, J.-P. Després, and C. Bouchard
Contribution of Body Fatness and Adipose Tissue Distribution to the Age Variation in Plasma Steroid Hormone Concentrations in Men: The HERITAGE Family Study
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1026 - 1031.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Ibanez, N. Potau, M. Zampolli, S. RiquE, P. Saenger, and A. Carrascosa
Hyperinsulinemia and Decreased Insulin-Like Growth Factor-Binding Protein-1 Are Common Features in Prepubertal and Pubertal Girls with a History of Premature Pubarche
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2283 - 2288.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Andersson, L.-A. Mattsson, L. Hahn, L. Lapidus, G. Holm, B.-A. Bengtsson, and P. Bjorntorp
Estrogen Replacement Therapy Decreases Hyperandrogenicity and Improves Glucose Homeostasis and Plasma Lipids in Postmenopausal Women With Noninsulin-Dependent Diabetes Mellitus
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 638 - 643.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Simon, M.-A. Charles, K. Nahoul, G. Orssaud, J. Kremski, V. Hully, E. Joubert, L. Papoz, and E. Eschwege
Association between Plasma Total Testosterone and Cardiovascular Risk Factors in Healthy Adult Men: The Telecom Study
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 682 - 685.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society